Pinkerton Retirement Specialists’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-1,047
Closed -$75.8K – 138
2023
Q3
$75.8K Buy
+1,047
New +$83.7K 0.02% 135

Other funds holding DNA

Pinkerton Retirement Specialists's DNA Position: Q4 2023 in Review

Pinkerton Retirement Specialists sold out of Ginkgo Bioworks (DNA) in Q4 2023, closing a stake of 1,047 shares — an estimated $75.8K sold.

Pinkerton Retirement Specialists first reported a position in DNA in Q3 2023 and held it in 1 quarter. The position peaked at $75.8K in Q3 2023. 342 funds tracked by Wall St. Rank hold DNA as of Q4 2023.

  • Pinkerton Retirement Specialists reported no remaining Ginkgo Bioworks position as of Q4 2023 after selling out during the quarter.
  • Pinkerton Retirement Specialists sold 1,047 Ginkgo Bioworks shares in Q4 2023, an estimated $75.8K.
  • Pinkerton Retirement Specialists first reported a position in Ginkgo Bioworks in Q3 2023 and held it in 1 quarter.
  • Pinkerton Retirement Specialists's Ginkgo Bioworks position peaked at $75.8K in Q3 2023.
  • 342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2023.

Based on Pinkerton Retirement Specialists's 13F filing for Q4 2023, filed 25 Jan 2024.